Press Release Eidam Welcomes Dr. Michael Kalden to Management Team Eidam Diagnostics Corporation announces Dr. Michael Kalden, M.D. as Chief Scientific Officer Richmond, BC – January 5, 2007 Eidam Diagnostics Corporation is pleased to announce that Dr. Michael Kalden, M.D. has been appointed as the Company’s Chief Scientific Officer, effective January 4, 2007. Dr. Kalden is a specialist in the field of oncology and holistic cancer therapy and has held numerous appointments with leading medical institutions in Germany. Dr. Kalden has used the CRT 2000® Thermographic System as a core part of his cancer detection and treatment monitoring protocol for over 10 years.  His areas of expertise also include naturopathy and pain control. Dr. Kalden is presently the head physician and medical director for the Veramed Hospital at Tannenberg Hospital, in which he specializes in holistic cancer therapy. He has held this position since 1989. In addition, he has been the co-founder of the Society of Biological Medicine, Inc. in Berlin-Mesched and has headed studies in the Mibeg Institute in Cologne, Germany. Recently, Dr. Kalden has opened a new private surgery for oncology and naturopathy in the Dortmund center for hyperthermia and continues his co-operation with the Panacea Center for Preventative Medicine and Research in Vancouver, B.C., Canada. Bernard Armani, CEO of Eidam Diagnostics, states, “We have always valued Dr. Kalden's support and generous contributions to the development of the CRT 2000®. It is now with great pleasure that we welcome Dr. Kalden's direct involvement as a member of the Eidam Team and we look forward to the ultimate benefit from his knowledge, guidance and expertise. Dr. Kalden will play a key role in both scientific and corporate growth of Eidam Diagnostics Corporation.     About Eidam Diagnostics Corporation Eidam Diagnostics Corporation is a privately held Canadian company headquartered in Richmond, British Columbia, with offices in German and China. The company's primary product, the CRT 2000® Thermographic System is intended for use in preventative healthcare, and is able to detect the changes in the body's temperature regulation to produce data that can be used for adjunctive diagnosis of certain diseases. The CRT 2000® is the only contact thermography device of its kind in the world. It is non-invasive, emits no radiation, and can be used repeatedly for treatment monitoring. The CRT 2000® has obtained CE accreditation and has been listed as a US FDA 510(k) Class I medical device. Eidam aims to prevent the progression of disease, by identifying the initial development of illnesses before symptoms manifest. For more information about Eidam Diagnostics Corporation, please contact Shelley Leonhardt, Senior Vice President, at (604) 304-6016 or visit our website at www.eidam.com. Return to Press Releases